Authors:
Monali Tayade, Sampada Kulkarni
Download free PDF
mHealth Services Market Size & Share 2026-2035
Report ID: GMI13865
|
Published Date: October 2026
|
Report Format: PDF/Excel/Dashboard/Platform
Explore Our Licensing Options:
mHealth Services Market
Get a free sample of this report
What are you hoping to find?
Your PDF is on its way. Tell us little about your research goal, and we'll help you find the most relevant market insights.
mHealth Services Market Size
The mHealth services market was valued at USD 62.0 billion in 2025, is expected to reach USD 71.3 billion in 2026, is projected to grow at a 13.5% CAGR (2025–2035), and is forecast to reach USD 220.0 billion by 2035. The market comprises revenue from remote monitoring, virtual diagnostics, digital care coordination, public health infrastructure, and consumer-facing mobile health services delivered through provider, payer, government, and direct-to-consumer channels.
mHealth Services Market Key Takeaways
Market Leader: Teladoc Health led with over 3.4% market share in 2025.
Leading Players: Top 5 players in this market include Teladoc Health, Apple, Samsung Electronics, Google, Vodafone Group, which collectively held a market share of 9.7% in 2025.
The mHealth services market is shifting from episodic virtual consultations toward longitudinal care models that combine connected-device data, clinician workflows, and patient engagement. Demand is being broadened by chronic disease management requirements, more permanent reimbursement arrangements, and national digital-health programs that position mobile services as care-delivery infrastructure rather than a supplemental channel.
GMI Analyst View
Our discussions with industry experts indicate that the mHealth services market generated USD 55.0 billion in revenue in 2024. We view this historic revenue base as evidence that the category entered the forecast period with established commercial demand, before broader adoption of AI-enabled clinical tools and connected-care service models.
mHealth Services Market Trends, Growth Drivers & GMI Forecast Outlook
AI-enabled care delivery, wearable-connected monitoring, and government digital-health programs are enlarging the service opportunity, while cybersecurity obligations and fragmented compliance requirements are extending implementation cycles. Growth will favor platforms able to translate clinical data into reimbursable, persistent care relationships without adding unsustainable integration burdens for providers.
Key Drivers
Evidence anchors use cited external data; demand implications and forecast conditions represent GMI analysis.
Chronic disease management provides the underlying service need for remote monitoring, medication support, and care coordination. Noncommunicable diseases caused at least 43 million deaths globally in 2021 and accounted for 75% of non-pandemic-related deaths worldwide, reinforcing the need for scalable models that keep patients connected between in-person encounters [1]World Health Organization. "Noncommunicable diseases." who.int. Mobile services are particularly relevant where specialist capacity is constrained and routine follow-up can be shifted from facility-centered care to continuous digital engagement.
Clinical AI is changing procurement requirements as health systems seek platforms that can prioritize patient risk, support remote interpretation, and reduce manual review burdens. The commercial value lies less in a standalone algorithm than in its ability to fit into clinical workflows, demonstrate reliability, and support reimbursement or value-based care arrangements. Providers that can deploy those capabilities within monitoring and virtual-care programs are better positioned to secure longer-duration service contracts.
Wearables broaden the pool of patients able to contribute health data outside traditional care settings. As consumer devices incorporate clinically relevant sensing functions, mHealth operators can create higher-frequency engagement models around post-acute recovery, chronic-condition surveillance, and preventive care. National reimbursement and digital identity programs further strengthen this opportunity by giving providers clearer routes to integrate mobile channels into institutional care delivery rather than treating them as disconnected consumer applications.
Key Restraints
Evidence anchors use cited external data; demand implications and forecast conditions represent GMI analysis.
Cybersecurity is a commercial constraint as well as a technical one because mHealth platforms depend on persistent flows of sensitive patient information. Healthcare breaches took an average of 279 days to identify and contain in the cited benchmark, leaving providers exposed to operational disruption, remediation obligations, and erosion of patient confidence [4]IBM Security / Ponemon Institute. "Healthcare remains costliest industry for breaches at $7.42M." healthtechsecurity.techtarget.com. Security architecture, audit readiness, and incident-response capabilities are therefore becoming preconditions for enterprise deployment rather than discretionary platform features.
The impact extends to buying behavior. Provider organizations facing active cyber risk may defer integrations that create additional vendor interfaces, while patients may limit participation when they do not trust how sensitive information will be used or protected. Larger operators can spread legal, security, and compliance investments across broader customer bases; smaller firms must decide whether to concentrate in a limited set of regulatory environments or accept a slower expansion path.
GMI Analyst View
We expect the market's most durable growth to come from platforms that make AI, monitoring data, and clinician intervention part of one operating model. The decisive constraint is not demand for virtual care; it is whether operators can meet security and compliance expectations without making deployment too expensive or operationally burdensome for provider customers.
mHealth Services Market Segment Analysis
By Service Type
Monitoring Services generated USD 24.8 billion in 2025 and are projected to account for 45% of the mHealth Services Market by 2035. The segment benefits from recurring use cases in chronic disease management, post-acute recovery, and continuous vital-sign tracking, where connected devices create repeated patient touchpoints and allow providers to intervene before an avoidable escalation.
Diagnosis Services represented 25% of market revenue in 2025 and are projected to reach USD 57.2 billion by 2035. Their expansion is supported by AI-assisted triage, asynchronous clinical review, and virtual pathways that extend diagnostic access beyond major urban care centers, although sustained adoption remains tied to clinical validation and workflow integration.
Healthcare Systems Strengthening Services held a 20% share in 2025 and are anticipated to grow at a 12.3% CAGR (2025–2035). Government-backed health identity, interoperability, and digital-care programs give this segment a relatively stable institutional foundation, but lengthy public procurement cycles can temper the speed with which program commitments become recognized service revenue.
Other mHealth Services accounted for 15% of revenue in 2025 and are forecast to reach USD 24.2 billion by 2035. Appointment reminders, health-information channels, and messaging services remain important access tools, particularly in lower-resource settings, but their strategic role is increasingly shaped by how effectively they connect users to higher-value monitoring, care-management, or diagnostic workflows.
By Application
Healthcare Management generated USD 19.8 billion in 2025 and is projected to hold a 39% market share by 2035. Chronic care coordination, post-acute support, and digital care-navigation programs align directly with provider efforts to manage populations over time, making this application central to value-based care and resource optimization initiatives.
General Healthcare & Fitness held a 33% share in 2025 and is projected to reach USD 72.6 billion by 2035. Consumer engagement remains the defining advantage of this application, but lasting monetization will increasingly depend on whether wellness platforms can connect activity, sleep, and other behavioral data to clinically relevant services without compromising user trust.
Medication Information accounted for 20% of market revenue in 2025 and is forecast to expand at a 13.1% CAGR (2025–2035). The application gains importance when medication reminders, prescription information, and adherence support are embedded within broader care-management platforms, enabling providers and payers to connect patient behavior with treatment continuity.
Other Applications represented 15% of revenue in 2025 and are projected to account for 8% by 2035. Mental health, insurance navigation, and specialized support tools continue to create targeted opportunities, although their relative market position is being overtaken by applications tied more directly to monitoring, clinical intervention, and recurring care-management contracts.
By End Use
Healthcare Providers generated USD 27.9 billion in 2025 and are projected to account for 44% of market revenue by 2035. Hospitals, clinics, and physician networks remain the principal institutional buyers because they require platforms that can integrate patient communications, remote monitoring, clinical documentation, and escalation processes into existing care delivery models.
Patients / Consumers held a 40% share in 2025 and are projected to reach USD 105.5 billion by 2035. Direct-to-consumer telehealth, digitally enabled chronic care, and device-linked services are expanding this channel, but providers with strong clinical credibility and frictionless onboarding will be better equipped to convert consumer engagement into durable utilization.
Other End Users accounted for 15% of revenue in 2025 and are anticipated to grow at a 6.6% CAGR (2025–2035). Payers, pharmaceutical companies, and public health organizations can provide important funding and distribution routes, although reimbursement negotiations and public-sector decision cycles make this channel less responsive than provider and consumer demand.
GMI Analyst View
We see the strongest strategic opportunity in service models that bridge institutional clinical workflows and consumer engagement. A monitoring platform that is easy for patients to use but also produces actionable information for care teams can defend its relevance more effectively than a point solution designed solely for either consumer acquisition or enterprise procurement.
mHealth Services Market Regional Analysis
North America mHealth Services Market Analysis
The North American mHealth Services Market generated USD 18.6 billion in 2025 and is projected to account for 24% of global revenue by 2035. Reimbursement continuity, sophisticated provider IT environments, and the adoption of clinical AI give the region a deep enterprise base, although stringent privacy and interoperability requirements favor operators with established compliance capabilities.
United States
The United States generated USD 15.8 billion in 2025 and is projected to reach USD 44.8 billion by 2035. Medicare and Medicaid reimbursement pathways, employer-sponsored virtual care, and broad health-system demand create the region's most developed mHealth commercial environment, while competition increasingly centers on integrated care experiences rather than teleconsultation capacity alone.
Canada
Canada generated USD 2.8 billion in 2025 and is expected to grow at a 12% CAGR (2025–2035). Provincial funding models and public digital-health infrastructure support measured expansion, but centralized purchasing structures require vendors to demonstrate interoperability, clinical utility, and value across heterogeneous provincial health systems.
Europe mHealth Services Market Analysis
The European mHealth Services Market generated USD 13.6 billion in 2025 and is projected to hold a 19% share of global revenue by 2035. The region combines expanding teleconsultation reimbursement with national electronic-record initiatives, creating a sizeable opportunity for services that can adapt to country-specific clinical, payment, and privacy requirements.
Germany
Germany is projected to reach USD 8.3 billion by 2035 and held a 20% share of European revenue in 2025. The DiGA reimbursement pathway and electronic patient record rollout support adoption of clinically oriented digital services, making regulatory qualification and evidence generation central competitive differentiators.
United Kingdom
The United Kingdom generated USD 3.0 billion in 2025 and is expected to grow at a 13% CAGR (2025–2035). NHS digital integration provides a population-scale distribution route, while provider adoption will depend on whether mHealth services can ease primary-care capacity pressure without increasing workflow complexity.
France
France is projected to reach USD 7.1 billion by 2035 and accounted for 17% of European revenue in 2025. Reimbursed teleconsultation and national digital-health infrastructure create a favorable setting for chronic care and patient-navigation services that can operate across public and private care channels.
Italy
Italy represented 12% of European revenue in 2025 and is projected to reach USD 4.5 billion by 2035. Digitization investment and telemedicine integration can help address regional differences in care access, particularly where mobile-first pathways offer an alternative to limited local specialist capacity.
Spain
Spain generated USD 1.5 billion in 2025 and is projected to reach USD 4.6 billion by 2035. Regional health programs and consumer wellness adoption support a mixed demand profile in which clinical services and patient-facing applications can expand together.
Netherlands
The Netherlands generated USD 1.0 billion in 2025 and is expected to grow at a 13% CAGR (2025–2035). Strong digital literacy and interoperable health infrastructure make the country a favorable environment for services that can translate connected data into coordinated care rather than simply add another patient-facing interface.
Asia Pacific mHealth Services Market Analysis
The Asia Pacific mHealth Services Market held a 35% share of global revenue in 2025 and is projected to reach USD 95.7 billion by 2035. National digital-health platforms, high smartphone adoption, and varied healthcare access needs make the region the leading source of forecast-period scale, with country models ranging from public infrastructure-led deployment to device-centered consumer ecosystems.
China
China generated USD 7.6 billion in 2025 and is projected to reach USD 36.4 billion by 2035. Internet hospital development and policy support for digital care are expanding access beyond leading urban centers, giving large platform operators an opportunity to combine virtual consultations, medication services, and chronic disease follow-up.
India
India generated USD 4.3 billion in 2025 and is projected to reach USD 28.7 billion by 2035. National health identity infrastructure and teleconsultation programs provide a public-sector foundation, while growing smartphone access supports private models that can serve urban and semi-urban populations through mobile-first delivery.
Japan
Japan accounted for 18% of Asia Pacific revenue in 2025 and is expected to grow at a 9% CAGR (2025–2035). Population aging supports sustained demand for remote chronic-care and post-acute monitoring, though the pace of market development reflects a comparatively cautious regulatory and clinical adoption environment.
South Korea
South Korea held a 10% share of Asia Pacific revenue in 2025 and is projected to reach USD 6.8 billion by 2035. High consumer technology adoption and established device ecosystems support connected-health service development, while reimbursement expansion will determine how quickly consumer-generated data becomes embedded in routine clinical pathways.
Australia
Australia generated USD 1.7 billion in 2025 and is projected to reach USD 4.4 billion by 2035. Permanent telehealth reimbursement and a mature national digital-health environment support continued use across both urban and regional communities, with private insurers adding another route for consumer-facing service adoption.
Latin America mHealth Services Market Analysis
The Latin American mHealth Services Market held an 8% share of global revenue in 2025 and is expected to grow at a 13% CAGR (2025–2035). Mobile-first service models address persistent access gaps across dispersed populations, although differing regulatory maturity and healthcare financing conditions create uneven opportunities across the region.
Brazil
Brazil generated USD 2.3 billion in 2025 and is projected to reach USD 8.3 billion by 2035. Permanent telemedicine regulation and public digital-health programs provide a stronger institutional base than in many regional markets, while private platforms can extend services across densely populated urban centers and underserved areas.
Mexico
Mexico held a 30% share of Latin American revenue in 2025 and is projected to reach USD 5.1 billion by 2035. Public telehealth programs and private mobile channels are addressing urban-rural care disparities, creating demand for services that can operate effectively where fixed broadband and specialist availability remain inconsistent.
Argentina
Argentina generated USD 600 million in 2025 and is expected to grow at a 12% CAGR (2025–2035). Private telehealth and wellness platforms offer a route to continued adoption, but economic volatility and constrained public health budgets may limit the pace of broad institutional implementation.
Middle East & Africa mHealth Services Market Analysis
The Middle East & Africa mHealth Services Market held a 5% global revenue share in 2025 and is projected to reach USD 11.5 billion by 2035. Gulf digital-health investment is creating sophisticated institutional demand, while mobile access in African markets supports service models designed to extend care beyond conventional facility networks.
Saudi Arabia
Saudi Arabia generated USD 900 million in 2025 and is projected to reach USD 3.9 billion by 2035. Health-sector transformation initiatives, virtual-hospital development, and digital infrastructure investment are strengthening the market for services that can support government providers as well as private clinical networks.
UAE
The UAE held a 22% share of Middle East & Africa revenue in 2025 and is projected to reach USD 2.8 billion by 2035. Advanced digital-health policy, service sophistication, and medical-tourism-related demand support virtual pre-consultation and connected-care use cases that require strong data governance and multilingual service delivery.
South Africa
South Africa generated USD 500 million in 2025 and is expected to grow at a 13% CAGR (2025–2035). Mobile penetration and health-system digitization create a foundation for connected care, while the implementation of public health reforms could expand longer-term opportunities beyond private urban provider networks.
GMI Analyst View
We view Asia Pacific as the market's principal scale engine because public infrastructure and private digital ecosystems are advancing in parallel. In Latin America and the Middle East & Africa, the more relevant competitive test will be whether mHealth providers can design mobile-first services that address access constraints without relying on the same level of hospital-system integration available in mature markets.
mHealth Services Market Share & Competitive Landscape
The mHealth services market share remains fragmented, with the Others category accounting for approximately 92.6% of global revenue in 2025. Fragmentation reflects country-specific reimbursement structures, local provider relationships, and the breadth of service models spanning consumer wellness, enterprise telehealth, public digital-health infrastructure, and specialized remote monitoring. Teladoc Health, Apple, and Samsung Electronics hold the largest individual shares among the companies in the competitive scope.
Teladoc Health held approximately 3.4% of global mHealth market share in 2025. Its position is supported by virtual primary care, chronic-condition management, behavioral health, and enterprise relationships with employers, health plans, and provider organizations. The company's strategic relevance rests on its ability to operate across multiple care settings while balancing care-delivery costs with the need for differentiated clinical services.
Apple held approximately 2.5% of global mHealth market share in 2025. Its competitive position stems from an extensive device ecosystem and the ability to connect consumer-generated health data with increasingly clinical use cases through Apple Health, HealthKit, and wearable sensing capabilities. The company is particularly well placed where consumer engagement, device interoperability, and clinical data integration converge.
Samsung Electronics held approximately 1.5% of global mHealth market share in 2025. Samsung Health and the Galaxy Wearables ecosystem provide a substantial consumer-health entry point, while clinical partnerships and regional device penetration create opportunities to extend those capabilities into remote monitoring and data-enabled care services.
Amwell remains focused on enterprise virtual care infrastructure for health systems, health plans, and employers. Google is expanding its clinical relevance through health-data, diagnostics, and AI capabilities, while Qualcomm Technologies supports the connectivity and edge-processing requirements of wearable and remote-monitoring ecosystems. Vodafone Group, Telefonica, and Orange use telecommunications assets to support connected-device management and digital-health services, particularly across European and Latin American markets.
Specialist firms occupy differentiated positions in clinically focused categories. AliveCor concentrates on AI-enabled cardiac monitoring, Veradigm supports data and engagement services for clinical and research networks, and AirStrip Technologies provides mobile clinical decision support and patient-data aggregation. Force Therapeutics addresses orthopedic and surgical recovery pathways, Spruce Health provides secure clinical communications and telemedicine tools, and SoftServe delivers digital-health engineering and implementation services for enterprise clients. Competitive advantage will increasingly depend on clinical validation, security posture, local compliance expertise, and the ability to integrate services into established care workflows.
Recent Industry Developments
Grindr Acquires PurposeMed (Freddie) - September 30, 2026 [6]Grindr Inc. "Grindr to Acquire Freddie, Expanding Access to HIV Prevention for Millions of Users." investors.grindr.com
Grindr agreed to acquire PurposeMed, the parent company of Freddie, in a transaction that broadens its participation in specialty telehealth and HIV prevention services. The planned integration under Grindr Health illustrates the strategic value of combining community-specific engagement channels with accessible, digitally delivered care models.
Sword Health Acquires Kaia Health - January 28, 2026 [7]Sword Health. "Sword Health acquires Kaia Health expanding reach to 100M people." swordhealth.com
Sword Health acquired Kaia Health, expanding its musculoskeletal and pulmonary digital-care capabilities across enterprise and reimbursed-care channels. The transaction underscores continuing consolidation among clinically oriented mHealth platforms seeking broader service portfolios, established patient access, and stronger positions in regulated digital-health markets.
Need a specific section of this report?
Purchase regional analysis, country-level analysis, company profiles, or any other segment-level insights separately
based on your research needs.
Frequently Asked Questions (FAQs):
Research methodology, data sources & validation process
This report draws on a structured research process built around direct industry conversations, proprietary modelling, and rigorous cross-validation and not just desk research.
Our 6-step research process
1. Research design & analyst oversight
At GMI, our research methodology is built on a foundation of human expertise, rigorous validation, and complete transparency. Every insight, trend analysis, and forecast in our reports is developed by experienced analysts who understand the nuances of your market.
Our approach integrates extensive primary research through direct engagement with industry participants and experts, complemented by comprehensive secondary research from verified global sources. We apply quantified impact analysis to deliver dependable forecasts, while maintaining complete traceability from original data sources to final insights.
2. Primary research
Primary research forms the backbone of our methodology, contributing nearly 80% to overall insights. It involves direct engagement with industry participants to ensure accuracy and depth in analysis. Our structured interview program covers regional and global markets, with inputs from C-suite executives, directors, and subject matter experts. These interactions provide strategic, operational, and technical perspectives, enabling well-rounded insights and reliable market forecasts.
3. Data mining & market analysis
Data mining is a key part of our research process, contributing nearly 20% to the overall methodology. It involves analysing market structure, identifying industry trends, and assessing macroeconomic factors through revenue share analysis of major players. Relevant data is collected from both paid and unpaid sources to build a reliable database. This information is then integrated to support primary research and market sizing, with validation from key stakeholders such as distributors, manufacturers, and associations.
4. Market sizing
Our market sizing is built on a bottom-up approach, starting with company revenue data gathered directly through primary interviews, alongside production volume figures from manufacturers and installation or deployment statistics. These inputs are then pieced together across regional markets to arrive at a global estimate that stays grounded in actual industry activity.
5. Forecast model & key assumptions
Every forecast includes explicit documentation of:
✓ Key growth drivers and their assumed impact
✓ Restraining factors and mitigation scenarios
✓ Regulatory assumptions and policy change risk
✓ Technology adoption curve parameter
✓ Macroeconomic assumptions (GDP growth, inflation, currency)
✓ Competitive dynamics and market entry/exit expectations
6. Validation & quality assurance
The final stages involve human validation, where domain experts manually review filtered data to identify nuances and contextual errors that automated systems might miss. This expert review adds a critical layer of quality assurance, ensuring data aligns with research objectives and domain-specific standards.
Our triple-layer validation process ensures maximum data reliability:
✓ Statistical Validation
✓ Expert Validation
✓ Market Reality Check
Trust & credibility
Verified data sources
Trade publications
Industry journals, trade publications, and specialized media.
Industry databases
Proprietary and third-party market databases
Regulatory filings
Government procurement records and policy documents
Academic research
University studies and specialist institution reports
Company reports
Annual reports, investor presentations, and filings
Expert interviews
C-suite, procurement leads, and technical specialists
GMI archive
13,000+ published studies across 20+ industry verticals
Trade data
Import/export volumes, HS codes, and customs records
Parameters studied & evaluated
Every data point in this report is validated through primary interviews, true bottom-up modelling, and rigorous cross-checks. Read about our research process →